Narrow search
Showing 1 - 4 of 4
Cover Image
Costs and benefits of innovation and regulation in the pharmaceutical industry
Hansen, Ronald W. - 1982
Persistent link: https://www.econbiz.de/10000332058
Cover Image
Drug regulation and innovation : empirical evidence and policy options
Grabowski, Henry G. - 1976
Persistent link: https://www.econbiz.de/10000584248
Cover Image
The impact of regulation on industrial innovation
Grabowski, Henry G.; Vernon, John M. - 1979
Persistent link: https://www.econbiz.de/10000830597
Cover Image
FDA Regulation of Biosimilars
Lietzan, Erika - 2015
The Biologics Price Competition and Innovation Act (BPCIA) was enacted in March 2010 as part of the Affordable Care Act (ACA). The objective of the BPCIA, like the Hatch-Waxman Amendments of 1984 for generic copies of non-biological drugs, was to increase price competition and generate cost...
Persistent link: https://www.econbiz.de/10013015283